Evaluation of corneal damage after vitrectomy and effect of Rebamipide ocular solution

Evaluation of corneal damage after vitrectomy and effect of Rebamipide ocular solution - corneal damage after vitrectomy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015888

Enrollment

Registered

2014-12-15

Start date

2014-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dry eye

Interventions

Add rebamipide ocular solution 4 times daily to patients. Do not use rebamipide ocular solution.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients that are going to undergo vitrectomy at our hospital

Exclusion criteria

Exclusion criteria: Patients that cannot make written informed consent.

Design outcomes

Primary

Measure	Time frame
To decrease postoperative dry eye syndrome after vitrectomy.	—

Secondary

Measure	Time frame
Conjunctival goblet cell decrease after vitrectomy.	—

Countries

Japan

Contacts

Public ContactMineo Kondo

MieUniversity Ophthalmology

mineo@clin.medic.mie-u.ac.jp059-232-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026